Relevance of GADF15 biomarker with left ventricular ejection fraction in coronary artery disease (CAD ) patients

Abstract

     The  correlation of new biomarkers with In patients with coronary artery disease (CAD), left ventricular ejection fraction.Globally, coronary artery disease is a significant non-communicable disease issue. Numerous significant risk factors, including smoking, diabetes mellitus, dyslipidemia, and hypertension, can result in coronary artery disease. [1]. patient heart failure management. When following up on heart failure cohorts over an extended period of time, plasma BNP or NT-proBNP is a highly effective independent predictor of death and morbidity. Furthermore, it seems to be a reliable indicator of a positive reaction when beta blocker is added to anti-heart failure medication. When changing therapy for heart failure based on serial measures of NT-proBNP, as opposed to altering therapy based on independent clinical judgment, better results are expected.